Kala Bio Inc (KALA)

May 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 03, 2026

Apr 27, 2026

Kala Bio chases 'Palantir for biotech' dream with new AI platform - MSN

Apr 27, 2026

Apr 27, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 27, 2026

Apr 26, 2026

Kala Bio rises on plans to leverage AI - MSN

Apr 26, 2026

Apr 24, 2026

Kala Bio Stock Just Plunged 92% Today – Here’s What Happened - MSN

Apr 24, 2026

Apr 24, 2026

KALA Stock Price, Quote & Chart | KALA BIO INC (NASDAQ:KALA) - ChartMill

Apr 24, 2026

Apr 23, 2026

KALA BIO (KALA) Stock Volatility | Q3 2025: EPS Tops ViewsElite Trading Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 21, 2026

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine - ADVFN

Apr 21, 2026

Apr 21, 2026

KALA BIO, Inc. (NASDAQ:KALA) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Apr 21, 2026

Apr 20, 2026

KALA BIO (KALA) Stock Shared Voting (Momentum Fading) 2026-04-20Gap Up Stocks - Xã Thanh Hà

Apr 20, 2026

Apr 17, 2026

$9.1 Billion Mesenchymal Stem Cell Market by 2031 to be Focused on by New Senior Scientific Advisor for KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com

Apr 17, 2026

Apr 17, 2026

$9.1 Billion Mesenchymal Stem Cell Market by 2031 to be Focused - openPR.com

Apr 17, 2026

Apr 16, 2026

Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA) - PRLog

Apr 16, 2026

Apr 16, 2026

Kala Bio Transitions to AI-Powered Biotech Solutions with Researgency Platform and MSC-S Asset Strategy 47 - Minichart

Apr 16, 2026

Apr 15, 2026

KALA BIO (NASDAQ:KALA) Posts Quarterly Earnings Results - MarketBeat

Apr 15, 2026

Apr 15, 2026

KALA BIO: Q4 Earnings Snapshot - Barchart

Apr 15, 2026

Apr 15, 2026

Eye-drug setback pushes KALA BIO (NASDAQ: KALA) toward high-risk AI bet - Stock Titan

Apr 15, 2026

Apr 11, 2026

KALA BIO, Inc. (NASDAQ:KALA) Sees Significant Drop in Short Interest - MarketBeat

Apr 11, 2026

Apr 10, 2026

Should I invest in Palisade Bio Inc before earnings2026 Performance Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

What is the bull case for KALA BIO (KALA) Stock | Price at $0.18, Up 0.17%Professional Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 09, 2026

Apr 08, 2026

Earnings Risk: What is KALA BIO Incs market position2026 Levels & Growth Focused Stock Reports - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Top 3 Health Care Stocks Which Could Blast Off This Quarter - Benzinga

Apr 08, 2026

Apr 08, 2026

What do insiders think about KALA BIO (KALA) Stock | Price at $0.17, Up 5.70%Fundamentals - Xã Vĩnh Công

Apr 08, 2026

Apr 06, 2026

Is KALA BIO (KALA) Stock Showing Strength | Price at $0.17, Up 2.70%Real Trader Insights - Xã Vĩnh Công

Apr 06, 2026

Apr 03, 2026

Kala Pharmaceuticals Inc (27F0.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

KALA Bio launches on-premises AI platform for biotech sector By Investing.com - Investing.com India

Apr 03, 2026

Apr 02, 2026

KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026

Apr 02, 2026

Kala Bio engages advisor to review clinical assets, AI analytics By Investing.com - Investing.com South Africa

Apr 02, 2026

Apr 02, 2026

KALA SEC FilingsKala Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 01, 2026

Kala Bio Delays 2025 Annual Report Filing - The Globe and Mail

Apr 01, 2026

Apr 01, 2026

KALA BIO, Inc. (KALA) stock price, news, quote and history - Yahoo Finance UK

Apr 01, 2026

Apr 01, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 01, 2026

Apr 01, 2026

Kala Bio engages advisor to review clinical assets, AI analytics - Investing.com

Apr 01, 2026

Apr 01, 2026

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities - manilatimes.net

Apr 01, 2026

Apr 01, 2026

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and ... - Caledonian Record

Apr 01, 2026

Apr 01, 2026

KALA Stock Analysis: KALA BIO Inc. Drops 5.83% to $0.16, Biotech Performance Review - UBND thành phố Hải Phòng

Apr 01, 2026

Mar 31, 2026

Kala Bio (NASDAQ: KALA) notifies SEC of late 2025 10‑K, cites turnover - Stock Titan

Mar 31, 2026

Mar 31, 2026

Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA) - Barchart.com

Mar 31, 2026

Mar 31, 2026

Bionic Intelligence Research Agent Now Commercially Live - openPR.com

Mar 31, 2026

Mar 31, 2026

User - The Chronicle-Journal

Mar 31, 2026

Mar 31, 2026

Kala Bio deploys AI research agent for biotech clients By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 30, 2026

Kala Bio Announces Initial Commercial Deployment of Bionic Intelligence Research Agent - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Exclusive: Penny stock Kala Bio transitions to revenue model with AI platform launch - MSN

Mar 30, 2026

Mar 30, 2026

Kala Bio deploys AI research agent for biotech clients - Investing.com

Mar 30, 2026

Mar 30, 2026

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live - The Manila Times

Mar 30, 2026